Pharmacological management of pancreatitis

Current Opinion in Pharmacology

Volumn 5, Issue 6 SPEC. ISS., 2005, Pages 578-582

  Hoogerwerf, Willemijntje A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALLOPURINOL; ANGIOPEPTIN; APROTININ; ASCORBIC ACID; BOTULINUM TOXIN; CYSTEINE; DICLOFENAC; GABEXATE MESILATE; GLYCEROL NITRATE; HYDROCORTISONE; INTERLEUKIN 10; LEUKOTRIENE; LEUKOTRIENE RECEPTOR; LIDOCAINE; LIPOXYGENASE; LOW MOLECULAR WEIGHT HEPARIN; MONTELUKAST; NIFEDIPINE; OCTREOTIDE; PLACEBO; PREDNISONE; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE INHIBITOR; SELENIUM; SERINE PROTEINASE; SOMATOSTATIN; TRYPSIN; ULINASTATIN; UNINDEXED DRUG;

CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME INHIBITION; HUMAN; MORBIDITY; MORTALITY; PAIN; PANCREATITIS; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SYSTEMATIC REVIEW;

EID: 27744496912     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.06.007     Document Type: Review

References (42)

1. M.W. Russo J.T. Wei M.T. Thiny L.M. Gangarosa A. Brown Y. Ringel N.J. Shaheen R.S. Sandler Digestive and liver diseases statistics Gastroenterology 126 2004 1448-1453
2. Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy Complications of ERCP Gastroinest Endoscopy 57 2003 633-638
3. D.C. Whitcomb Acute pancreatitis: Molecular biology update J Gastrointest Surg 7 2003 940-942
4. D.C. Whitcomb M.C. Gorry R.A. Preston W. Furey M.J. Sossenheimer C.D. Ulrich S.P. Martin L.K. Gates Jr. S.T. Amann P.P. Toskes et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene Nat Genet 14 1996 141-145
5. D.C. Whitcomb Hereditary pancreatitis: New insights into acute and chronic pancreatitis Gut 45 1999 317-322
6. The Burden of Gastrointestinal Diseases. American Gastroenterological Association; 2001:48-50.
7. 1 esterase Biochim Biophys Acta 484 1977 417-422
8. N. Kuno T. Kasugai T. Oguki A. Matsuura K. Fujuwara K. Kurimoto O. Kato Study on prevention of complications associated with endoscopic retrograde cholangiopancreatography (ERCP): A controlled trial of a new protease inhibitor, Foy, in hyperamylasemia following endoscopic retrograde cholangiopancreatography Gendai Iryo 10 1978 571
9. G. Cavallini A. Tittobello L. Frulloni E. Masci A. Mariana V. Di Francesco Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy - Italian Group N Engl J Med 335 1996 919-923
10. E. Masci G. Cavallini A. Mariani L. Frulloni P.A. Testoni S. Curioni A. Tittobello G. Uomo G. Costamagna S. Zambelli et al. Gabexate in Digestive Endoscopy-Italian Group II. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis Am J Gastroenterol 98 2003 2182-2186
11. A. Andriulli L. Solmi S. Loperfido P. Leo V. Festa A. Belmonte F. Spirito M. Silla G. Forte V. Terruzzi et al. Prophylaxis of ERCP-related pancreatitis: A randomized, controlled trial of somatostatin and gabexate mesylate Clin Gastroenterol Hepatol 2 2004 713-718
12. Y. Matsukawa S. Nishinarita S. Sawada T. Horie Fatal cases of gabexate mesilate-induced anaphylaxis Int J Clin Pharmacol Res 22 2002 81-83
13. S.Y. Chen J.Y. Wang Shanghai Collaboration Group on Ulinastatin Clinical Trials Ulinastatin in the treatment of acute pancreatitis: A multicenter clinical trial Chin J Dig Dis 3 2002 70-75
14. T. Tsujino Y. Komatsu H. Isayama K. Hirano N. Sasahira N. Yamamoto N. Toda Y. Ito Y. Nakai M. Tada et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: A randomized, controlled trial Clin Gastroenterol Hepatol 3 2005 376-383
15. A. Andriulli G. Leandro G. Niro A. Mangia V. Festa G. Gambassi M.R. Villani D. Facciorusso P. Conoscitore F. Spirito G. De Maio Pharmacologic treatment can prevent pancreatic injury after ERCP: A meta-analysis Gastrointest Endosc 51 2000 1-7
16. A. Andriulli R. Clemente L. Solmi V. Terruzzi R. Suriani A. Sigillito G. Leandro P. Leo G. De Maio F. Perri Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: A multicenter, placebo-controlled, randomized clinical trial Gastrointest Endosc 56 2002 488-495
17. R.T. Poon C. Yeung C.L. Liu C.M. Lam W.K. Yuen C.M. Lo A. Tang S.T. Fan Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: A randomised controlled trial Gut 52 2003 1768-1773
18. D. Arvanitidis G.K. Anagnostopoulos D. Giannopoulos A. Pantes R. Agaritsi G. Margantinis S. Tsiakos G. Sakorafas P. Kostopoulos Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial J Gastroenterol Hepatol 19 2004 278-282
19. P. Katsinelos J. Kountouras G. Paroutoglou A. Beltsis K. Mimidis C. Zavos Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis Gastrointest Endosc 62 2005 105-111
20. J.J. Schwartz R.J. Lew N.A. Ahmad J.N. Shah G.G. Ginsberg M.L. Kochman C.M. Brensinger W.B. Long The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis Gastrointest Endosc 59 2004 179-184
21. A. Gorelick J. Barnett W. Chey M. Anderson G. Elta Botulinum toxin injection after biliary sphincterotomy Endoscopy 36 2004 170-173
22. T. Rabenstein B. Fischer V. Wiessner H. Schmidt M. Radespiel-Troger J. Hochberger S. Muhldorfer G. Nusko H. Messmann J. Scholmerich et al. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis Gastrointest Endosc 59 2004 606-613
23. B. Murray R. Carter C. Imrie S. Evans C. O'Suilleabhain Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography Gastroenterology 124 2003 1786-1791
24. M. Moreto M. Zaballa I. Casado O. Merino M. Rueda K. Ramirez R. Urcelay A. Baranda Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial Gastrointest Endosc 57 2003 1-7
25. S. Sudhindran E. Bromwich P.R. Edwards Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis Br J Surg 88 2001 1178-1182
26. F. Prat J. Amaris B. Ducot M. Bocquentin J. Fritsch A.D. Choury G. Pelletier C. Buffet Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study Gastrointest Endosc 56 2002 202-208
27. S. Manolakopoulos A. Avgerinos J. Vlachogiannakos A. Armonis N. Viazis N. Papadimitriou N. Mathou G. Stefanidis G. Rekoumis E. Vienna et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: A multicenter randomized controlled trial Gastrointest Endosc 55 2002 470-475
28. J. Deviere O. Le Moine J.L. Van Laethem P. Eisendrath A. Ghilain N. Severs M. Cohard Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography Gastroenterology 120 2001 498-505
29. A. Budzynska T. Marek A. Nowak R. Kaczor E. Nowakowska-Dulawa A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis Endoscopy 33 2001 766-772
30. T. Seta Y. Noguchi T. Shimada S. Shikata T. Fukui Treatment of acute pancreatitis with protease inhibitors: A meta-analysis Eur J Gastroenterol Hepatol 16 2004 1287-1293
31. V.P. Singh S.T. Chari Protease inhibitors in acute pancreatitis: Lessons from the bench and failed clinical trials Gastroenterology 128 2005 2172-2174
32. I.T. Virlos J. Mason D. Schofield R.F. McCloy J.M. Eddleston A.K. Siriwardena Intravenous n-acetylcysteine, ascorbic acid and selenium-based anti-oxidant therapy in severe acute pancreatitis Scand J Gastroenterol 38 2003 1262-1267
33. M.T. Cartmell D.A. O'Reilly C. Porter A.N. Kingsnorth A double-blind placebo-controlled trial of a leukotriene receptor antagonist in chronic pancreatitis in humans J Hepatobiliary Pancreat Surg 11 2004 255-259
34. P. Levy P. Hastier R. Arotcarena E. Bartolie M. Bouegeard-Julien J. Blumberg D. O'Tolle P. Ruszniewski Efficacy of lanreotide 30 mg on prevention of pain relapse after oral refeeding in patients with necrotizing acute pancreatitis. A phase II prospective multicentre study Pancreatology 4 2004 229-232
35. S. Nystedt K. Emilsson A.K. Larsson B. Strombeck J. Sundelin Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2 Eur J Biochem 232 1995 84-89
36. S.K. Bohm W. Kong D. Bromme S.P. Smeekens D.C. Anderson A. Connolly M. Kahn N.A. Nelken S.R. Coughlin D.G. Payan et al. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2 Biochem J 314 1996 1009-1016
37. M. Molino E.S. Barnathan R. Numerof J. Clark M. Dreyer A. Cumashi J.A. Hoxie N. Schechter M. Woolkalis L.F. Brass Interactions of mast cell tryptase with thrombin receptors and PAR-2 J Biol Chem 272 1997 4043-4049
38. W. Namkung W. Han X. Luo S. Muallem K.H. Cho K.H. Kim M.G. Lee Proteinase-activated receptor 2 exerts local protection and mediates some systemic complications in acute pancreatitis Gastroenterology 126 2004 1844-1859
39. A. Sharma X. Tao A. Gopal B. Ligon P. Andrade-Gordon M.L. Steer G. Perides Protection against acute pancreatitis by activation of protease-activated receptor-2 Am J Physiol Gastrointest Liver Physiol 288 2005 G388-G395
40. W.A. Hoogerwerf L. Zou M. Shenoy D. Sun M.A. Micci H. Lee-Hellmich S.Y. Xiao J.H. Winston P.J. Pasricha The proteinase-activated receptor 2 is involved in nociception J Neurosci 21 2001 9036-9042
41. W.A. Hoogerwerf M. Shenoy J.H. Winston S.Y. Xiao Z. He P.J. Pasricha Trypsin mediates nociception via the proteinase-activated receptor 2: A potentially novel role in pancreatic pain Gastroenterology 127 2004 883-891
42. W.A. Hoogerwerf K. Gondesen S.Y. Xiao J.H. Winston W.D. Willis P.J. Pasricha The role of mast cells in the pathogenesis of pain in chronic pancreatitis BMC Gastroenterol 5 2005 8